0000937556-17-000065.txt : 20170404
0000937556-17-000065.hdr.sgml : 20170404
20170404171802
ACCESSION NUMBER: 0000937556-17-000065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170331
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MASIMO CORP
CENTRAL INDEX KEY: 0000937556
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 330368882
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-297-7000
MAIL ADDRESS:
STREET 1: 52 DISCOVERY
CITY: IRVINE
STATE: CA
ZIP: 92618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: de Raad Mark
CENTRAL INDEX KEY: 0001363597
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33642
FILM NUMBER: 17739644
MAIL ADDRESS:
STREET 1: 40 PARKER
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_149134066727654.xml
FORM 4
X0306
4
2017-03-31
0
0000937556
MASIMO CORP
MASI
0001363597
de Raad Mark
C/O MASIMO CORPORATION
52 DISCOVERY
IRVINE
CA
92618
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2017-03-31
4
M
0
6000
37.84
A
14660
D
Common Stock
2017-03-31
4
S
0
6000
93.1323
D
8660
D
Common Stock
2017-03-31
4
M
0
12000
31.01
A
20660
D
Common Stock
2017-03-31
4
S
0
12000
93.135
D
8660
D
Common Stock
2017-04-03
4
M
0
12000
21.97
A
20660
D
Common Stock
2017-04-03
4
S
0
12000
93.3121
D
8660
D
Common Stock
2017-04-04
4
M
0
18000
28.03
A
26660
D
Common Stock
2017-04-04
4
S
0
18000
93.3354
D
8660
D
Non-Qualified Stock Option (Right to Buy)
37.84
2017-03-31
4
M
0
6000
37.84
D
2017-02-28
2026-02-28
Common Stock
6000.0
24000
D
Non-Qualified Stock Option (Right to Buy)
31.01
2017-03-31
4
M
0
12000
31.01
D
2016-03-20
2025-03-20
Common Stock
12000.0
18000
D
Non-Qualified Stock Option (Right to Buy)
21.97
2017-04-03
4
M
0
12000
21.97
D
2014-05-28
2023-05-28
Common Stock
12000.0
12000
D
Non-Qualified Stock Option (Right to Buy)
28.03
2017-04-04
4
M
0
18000
28.03
D
2015-02-18
2024-02-18
Common Stock
18000.0
12000
D
The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 17, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.77 per share to a high of $93.48 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $93.50 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $94.67 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.94 per share to a high of $93.83 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option was granted on February 29, 2016 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
This option was granted on March 20, 2015 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
This option was granted on February 18, 2014 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
/s/ David J. Van Ramshorst, Attorney-In-Fact
2017-04-04